Previous Close | 19.60 |
Open | 19.85 |
Bid | 19.00 |
Ask | 22.25 |
Strike | 137.00 |
Expire Date | 2024-08-02 |
Day's Range | 19.15 - 19.85 |
Contract Range | N/A |
Volume | |
Open Interest | 76 |
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. ...
Scientists have long worried about the potential pandemic threat posed by the virus. Three humans in the U.S. have been infected during the current outbreak.
(Bloomberg) -- Moderna Inc. secured nearly $200 million from the US government to speed development of an mRNA vaccine for pandemic influenza as a dangerous strain of bird flu sweeps through the nation’s dairy farms, fueling concern about a budding health crisis. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineePowerful Hurricane Beryl Aims at Jamaica After Grenada StrikeTrump Immunity Ruling Means Any Trial Before Election Unlikely‘Upflation’ Is the New Reta